Your browser doesn't support javascript.
loading
ETX2514 is a broad-spectrum ß-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
Durand-Réville, Thomas F; Guler, Satenig; Comita-Prevoir, Janelle; Chen, Brendan; Bifulco, Neil; Huynh, Hoan; Lahiri, Sushmita; Shapiro, Adam B; McLeod, Sarah M; Carter, Nicole M; Moussa, Samir H; Velez-Vega, Camilo; Olivier, Nelson B; McLaughlin, Robert; Gao, Ning; Thresher, Jason; Palmer, Tiffany; Andrews, Beth; Giacobbe, Robert A; Newman, Joseph V; Ehmann, David E; de Jonge, Boudewijn; O'Donnell, John; Mueller, John P; Tommasi, Rubén A; Miller, Alita A.
Afiliação
  • Durand-Réville TF; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Guler S; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Comita-Prevoir J; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Chen B; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Bifulco N; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Huynh H; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Lahiri S; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Shapiro AB; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • McLeod SM; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Carter NM; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Moussa SH; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Velez-Vega C; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Olivier NB; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • McLaughlin R; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Gao N; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Thresher J; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Palmer T; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Andrews B; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Giacobbe RA; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Newman JV; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Ehmann DE; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • de Jonge B; AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • O'Donnell J; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Mueller JP; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Tommasi RA; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
  • Miller AA; Entasis Therapeutics, 35 Gatehouse Drive, Waltham, Massachusetts 02451, USA.
Nat Microbiol ; 2: 17104, 2017 Jun 30.
Article em En | MEDLINE | ID: mdl-28665414
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acinetobacter baumannii / Compostos Azabicíclicos / Inibidores de beta-Lactamases / Bactérias Gram-Negativas Limite: Animals / Humans Idioma: En Revista: Nat Microbiol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acinetobacter baumannii / Compostos Azabicíclicos / Inibidores de beta-Lactamases / Bactérias Gram-Negativas Limite: Animals / Humans Idioma: En Revista: Nat Microbiol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos